BeyondSpring Inc. (BYSI) vs TransCode Therapeutics Inc. (RNAZ)
BeyondSpring Inc. and TransCode Therapeutics Inc. are both Biotechnology companies. BeyondSpring Inc. and TransCode Therapeutics Inc. are of similar size ($29.8M and $27.9M). Across the 8 metrics below, BeyondSpring Inc. leads on 5 and TransCode Therapeutics Inc. on 3.
Valuation
Profitability
| Metric | BYSI | RNAZ | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 24.96% | 429.61% | (57.72%) |
| Return on assets | (29.29%) | (58.12%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack